Cleared Traditional

K760933 - BARRIER UNIVERSAL SHEET

K760933 is an FDA 510(k) clearance for BARRIER UNIVERSAL SHEET, manufactured by Surgikos, Inc.. The device is a Class 2 General Hospital device with product code KKX cleared through the Traditional 510(k) pathway after a 13-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1976
Decision
13d
Days
Class 2
Risk

K760933 is an FDA 510(k) clearance for the BARRIER UNIVERSAL SHEET. Classified as Drape, Surgical (product code KKX), Class II - Special Controls.

Submitted by Surgikos, Inc. (Mchenry, US). The FDA issued a Cleared decision on November 11, 1976 after a review of 13 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 878.4370 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Surgikos, Inc. devices

FDA 510(k) Submission Details - K760933

510(k) Number K760933 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 29, 1976
Decision Date November 11, 1976
Days to Decision 13 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
116d faster than avg
Panel avg: 129d · This submission: 13d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KKX Device Classification - Class 2, Special Controls

Product Code KKX Drape, Surgical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4370
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - KKX Drape, Surgical

All 228
Devices cleared under the same product code (KKX) and FDA review panel - the closest regulatory comparables to K760933.
BARRIER NEURO SHEET
K760937 · Surgikos, Inc. · Dec 1976
BARRIER IMPERVIOUS S-OCKINETTE
K760890 · Surgikos, Inc. · Nov 1976
BOUNDARY FABRIC III SURGICAL DRAPE
K760932 · Procter & Gamble Mfg. Co. · Nov 1976
BARRIER GENERAL SURGERY PACK
K760807 · Surgikos, Inc. · Nov 1976
STERILE STOCKINETTE
K760867 · Abco Dealers, Inc. · Nov 1976
DRAPES, BARRIER, STERILE PATIENT READY
K760212 · Surgikos, Inc. · Aug 1976